Neoadjuvant treatment of esophageal cancer
- PMID: 20698042
- PMCID: PMC2921091
- DOI: 10.3748/wjg.v16.i30.3793
Neoadjuvant treatment of esophageal cancer
Abstract
The management of esophageal cancer has been evolving over the past 30 years. In the United States, multimodality treatment combining chemotherapy and radiotherapy (RT) prior to surgical resection has come to be accepted by many as the standard of care, although debate about its overall effect on survival still exists, and rightfully so. Despite recent improvements in detection and treatment, the overall survival of patients with esophageal cancer remains lower than most solid tumors, which highlights why further advances are so desperately needed. The aim of this article is to provide a complete review of the history of esophageal cancer treatment with the addition of chemotherapy, RT, and more recently, _targeted agents to the surgical management of resectable disease.
Similar articles
-
Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?J Gastroenterol Hepatol. 2009 May;24(5):708-10. doi: 10.1111/j.1440-1746.2009.05838.x. J Gastroenterol Hepatol. 2009. PMID: 19646012 No abstract available.
-
Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management.Gen Thorac Cardiovasc Surg. 2016 Jul;64(7):386-94. doi: 10.1007/s11748-016-0655-y. Epub 2016 May 10. Gen Thorac Cardiovasc Surg. 2016. PMID: 27165288 Review.
-
Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.Ann Thorac Surg. 2008 Apr;85(4):1217-23; discussion 1223-4. doi: 10.1016/j.athoracsur.2007.11.070. Ann Thorac Surg. 2008. PMID: 18355499
-
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial.Dis Esophagus. 2019 Feb 1;32(2). doi: 10.1093/dote/doy078. Dis Esophagus. 2019. PMID: 30137281 Clinical Trial.
-
The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.Best Pract Res Clin Gastroenterol. 2007;21(6):947-63. doi: 10.1016/j.bpg.2007.10.005. Best Pract Res Clin Gastroenterol. 2007. PMID: 18070697 Review.
Cited by
-
Radiomics models based on CT at different phases predicting lymph node metastasis of esophageal squamous cell carcinoma (GASTO-1089).Front Oncol. 2022 Oct 26;12:988859. doi: 10.3389/fonc.2022.988859. eCollection 2022. Front Oncol. 2022. PMID: 36387160 Free PMC article.
-
Metastatic Esophageal Adenocarcinoma Presenting as Neck Dermal Metastasis.Case Rep Dermatol Med. 2024 Jan 16;2024:7951391. doi: 10.1155/2024/7951391. eCollection 2024. Case Rep Dermatol Med. 2024. PMID: 38264294 Free PMC article.
-
Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo.Cancer Cell Int. 2014 Jul 18;14:71. doi: 10.1186/s12935-014-0071-2. eCollection 2014. Cancer Cell Int. 2014. PMID: 25788859 Free PMC article.
-
An EGFR/HER2-Bispecific and enediyne-energized fusion protein shows high efficacy against esophageal cancer.PLoS One. 2014 Mar 24;9(3):e92986. doi: 10.1371/journal.pone.0092986. eCollection 2014. PLoS One. 2014. PMID: 24664246 Free PMC article.
-
Nomogram based on multimodal magnetic resonance combined with B7-H3mRNA for preoperative lymph node prediction in esophagus cancer.World J Clin Oncol. 2024 Mar 24;15(3):419-433. doi: 10.5306/wjco.v15.i3.419. World J Clin Oncol. 2024. PMID: 38576593 Free PMC article.
References
-
- Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer. 2001;92:549–555. - PubMed
-
- Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142–146. - PubMed
-
- Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–2150. - PubMed
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
-
- Eslick GD. Epidemiology of esophageal cancer. Gastroenterol Clin North Am. 2009;38:17–25, vii. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous